New Study Shows Cannabis May Help Reduce Opioid Use Among Chronic Pain Patients

A new study published in the Journal of the American Medical Association suggests that cannabis could be an effective alternative to opioids for chronic pain management. The study, which analyzed data from 27 randomized clinical trials involving 2,454 patients, found that cannabis use was associated with a significant reduction in opioid use among chronic pain patients.

​

The study's lead author, Dr. Emily Earlenbaugh, noted that "cannabis has been shown to be effective in treating a variety of types of chronic pain, including neuropathic pain, cancer pain, and pain related to multiple sclerosis." She added that "given the current opioid epidemic in the United States, it's crucial that we explore alternative treatments that can help reduce the use of these highly addictive drugs."

​

While the study's findings are promising, experts caution that more research is needed to fully understand the effects of cannabis on chronic pain. Some have also pointed out that cannabis use carries its own risks, such as impairment and the potential for addiction.

​

Still, advocates for marijuana legalization see the study as further evidence that cannabis should be considered a viable treatment option for chronic pain patients. "This study underscores the urgent need to remove barriers to cannabis research and allow patients to have access to this safe and effective medicine," said Erik Altieri, executive director of the National Organization for the Reform of Marijuana Laws (NORML).

​

The study's authors acknowledge that there are still many unanswered questions about the use of cannabis for pain management, and they call for more research to be done in this area. However, they believe that their findings provide a strong foundation for further exploration of the potential benefits of cannabis for chronic pain patients.